The Tocilizumab Injection, cataloged under National Stock Number 6505-01-687-8205, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Genentech Usa, Inc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: EA.
| Parameter | Value |
|---|---|
| NSN | 6505-01-687-8205 |
| Primary Part Number | NDC50242-0137-01 |
| Item Name | Tocilizumab Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Genentech Usa, Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | EA |
| Part Number | Manufacturer |
|---|---|
| NDC50242-0137-01 PRIMARY | Genentech Usa, Inc (USA) |
| Reference | Meaning |
|---|---|
| 1573216 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM206207 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-687-8205 is a Tocilizumab Injection, manufactured by Genentech Usa, Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-687-8205 has 1 manufacturer part number on file: NDC50242-0137-01 (Genentech Usa, Inc).
Key specifications for NDC50242-0137-01: Special Features: ACTEMRA (TOCILIZUMAB) IS AN INTERLEUKIN-6 (IL-6) RECEPTOR ANTAGONIST INDICATED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS, GIANT CELL ARTERITIS, POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, SYSTEMIC JUVENILE ARTHRITIS, AND CYTOKINE RELEASE SYNDROME (CRS); INTRAVENOUS INFUSION ONLY AFTER DILUTION; 400MG/20ML; SINGLE-USE VIAL; DISCARD UNUSED PORTION; NO PRESERVATIVE; ACTEMRA (TOCILIZUMAB) INJECTION IS A PRESERVATIVE-FREE,STERILE CLEAR, COLORLESS TO PALE YELLOW SOLUTION. STORE AT 2 C TO 8 C (36 F TO 46 F). DO NOT FREEZE.; Part Name Assigned by Controlling Agency: TOCILIZUMAB INJECTION, 400MG/20ML, ONE VIAL. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.